Global Nail Psoriasis Treatment Market Research Report 2026

Nail Psoriasis Treatment Market

Nail psoriasis treatment refers to a comprehensive management approach targeting psoriatic involvement of the nail unit—nail plate, nail bed, nail matrix, and periungual tissue—manifesting as pitting, onycholysis, subungual hyperkeratosis, discoloration, and crumbling. The goals are to reduce inflammation, restore nail structure and appearance, relieve pain and functional limitation, and mitigate relapse and complication risks. Therapeutic strategies are inherently “local plus systemic”: limited nail involvement is often managed with topical therapies, occlusion approaches, and selected intralesional procedures; more extensive nail disease, concomitant moderate-to-severe skin psoriasis, or elevated psoriatic arthritis risk frequently warrants systemic therapy (conventional systemics, small molecules, and/or biologics) with longitudinal follow-up.The average gross profit margin of this product is 55%.

Nail involvement is associated with higher disease burden and quality-of-life impairment and is often viewed as a clinically meaningful “high-impact” domain, strengthening patient demand for visible improvement and pushing dermatology care toward more refined, site-specific management. In parallel, maturation of biologic and systemic care pathways and wider adoption of standardized follow-up frameworks reinforce a credible clinical and reimbursement narrative—shifting nail psoriasis from a historically difficult-to-treat area toward measurable, sustainable improvement and expanding specialty-care demand. Responses are slow and heterogeneous, and matrix- vs bed-dominant disease requires different delivery approaches; without structured phenotyping and standardized protocols, outcomes can be inconsistent and adherence can erode. Topicals and intralesional procedures face operational and tolerability barriers, while systemic therapy introduces long-term monitoring, comedication complexity, and cost constraints—creating real-world sustainability hurdles. Additional risks include delayed diagnosis due to confounders (e.g., co-existing onychomycosis) and access variability driven by regional guideline, reimbursement, and prescribing restrictions. Demand is moving from “single-agent trials” to stratified combination strategies: limited nail involvement increasingly prioritizes high-efficacy topical regimens (often steroid plus vitamin D analog) and site-specific protocols for matrix vs bed disease, with intralesional options used when higher targeting is needed; broader disease more often favors systemic therapy to capture integrated benefits across skin, nails, and joint-risk management. Rising expectations for speed of improvement, cosmetic recovery, and durable maintenance are also accelerating adoption of more user-friendly delivery formats (penetration-enhanced vehicles, occlusive systems, home-usable regimens) and digital follow-up tools to support adherence. “Upstream” in this space is primarily defined by drug and delivery-platform capabilities. Topical products rely on high-purity actives and stable vehicles engineered for nail-unit barrier challenges (penetration enhancement, film-forming/occlusion, controlled release, and low-irritancy excipients). Intralesional approaches require sterile formulations with controlled physicochemical properties and compatible devices. Systemic therapy depends on robust upstream raw materials, process consistency, and quality systems (and, for biologics, cold-chain readiness). As evidence expectations rise for high-impact domains, capabilities in endpoint design, real-world data quality, and pharmacovigilance are increasingly treated as upstream determinants of competitiveness and access efficiency.

This report delivers a comprehensive overview of the global Nail Psoriasis Treatment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nail Psoriasis Treatment. The Nail Psoriasis Treatment market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Nail Psoriasis Treatment market comprehensively. Regional market sizes by Type, by Application, by Sales Channel, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Nail Psoriasis Treatment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Nail Psoriasis Treatment Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nail Psoriasis Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Topical Corticosteroids

1.2.3 Vitamin D Analogues

1.2.4 Systemic Biologics

1.2.5 Small-molecule Inhibitors

1.3 Market by Sales Channel

1.3.1 Global Nail Psoriasis Treatment Market Size Growth Rate by Sales Channel: 2021 vs 2025 vs 2032

1.3.2 Retail Pharmacies

1.3.3 Hospital Pharmacies

1.3.4 Online Pharmacies

1.4 Market by Route of Administration

1.4.1 Global Nail Psoriasis Treatment Market Size Growth Rate by Route of Administration: 2021 vs 2025 vs 2032

1.4.2 Topical

1.4.3 Oral

1.5 Market by Application

1.5.1 Global Nail Psoriasis Treatment Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Dermatology Clinics

1.5.3 Hospital

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2.1 Global Nail Psoriasis Treatment Market Perspective (2021–2032)

2.2 Global Nail Psoriasis Treatment Growth Trends by Region

2.2.1 Global Nail Psoriasis Treatment Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Nail Psoriasis Treatment Historic Market Size by Region (2021–2026)

2.2.3 Nail Psoriasis Treatment Forecasted Market Size by Region (2027–2032)

2.3 Nail Psoriasis Treatment Market Dynamics

2.3.1 Nail Psoriasis Treatment Industry Trends

2.3.2 Nail Psoriasis Treatment Market Drivers

2.3.3 Nail Psoriasis Treatment Market Challenges

2.3.4 Nail Psoriasis Treatment Market Restraints

3.1 Global Top Nail Psoriasis Treatment Players by Revenue

3.1.1 Global Top Nail Psoriasis Treatment Players by Revenue (2021–2026)

3.1.2 Global Nail Psoriasis Treatment Revenue Market Share by Players (2021–2026)

3.2 Global Top Nail Psoriasis Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Nail Psoriasis Treatment Revenue

3.4 Global Nail Psoriasis Treatment Market Concentration Ratio

3.4.1 Global Nail Psoriasis Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nail Psoriasis Treatment Revenue in 2025

3.5 Global Key Players of Nail Psoriasis Treatment Head Offices and Areas Served

3.6 Global Key Players of Nail Psoriasis Treatment, Products and Applications

3.7 Global Key Players of Nail Psoriasis Treatment, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4.1 Global Nail Psoriasis Treatment Historic Market Size by Type (2021–2026)

4.2 Global Nail Psoriasis Treatment Forecasted Market Size by Type (2027–2032)

5.1 Global Nail Psoriasis Treatment Historic Market Size by Application (2021–2026)

5.2 Global Nail Psoriasis Treatment Forecasted Market Size by Application (2027–2032)

6.1 North America Nail Psoriasis Treatment Market Size (2021–2032)

6.2 North America Nail Psoriasis Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Nail Psoriasis Treatment Market Size by Country (2021–2026)

6.4 North America Nail Psoriasis Treatment Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7.1 Europe Nail Psoriasis Treatment Market Size (2021–2032)

7.2 Europe Nail Psoriasis Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Nail Psoriasis Treatment Market Size by Country (2021–2026)

7.4 Europe Nail Psoriasis Treatment Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8.1 Asia-Pacific Nail Psoriasis Treatment Market Size (2021–2032)

8.2 Asia-Pacific Nail Psoriasis Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Nail Psoriasis Treatment Market Size by Region (2021–2026)

8.4 Asia-Pacific Nail Psoriasis Treatment Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9.1 Latin America Nail Psoriasis Treatment Market Size (2021–2032)

9.2 Latin America Nail Psoriasis Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Nail Psoriasis Treatment Market Size by Country (2021–2026)

9.4 Latin America Nail Psoriasis Treatment Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Nail Psoriasis Treatment Market Size (2021–2032)

10.2 Middle East & Africa Nail Psoriasis Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Nail Psoriasis Treatment Market Size by Country (2021–2026)

10.4 Middle East & Africa Nail Psoriasis Treatment Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Nail Psoriasis Treatment Introduction

11.1.4 AbbVie Revenue in Nail Psoriasis Treatment Business (2021–2026)

11.1.5 AbbVie Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Nail Psoriasis Treatment Introduction

11.2.4 Johnson & Johnson Revenue in Nail Psoriasis Treatment Business (2021–2026)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Nail Psoriasis Treatment Introduction

11.3.4 Novartis Revenue in Nail Psoriasis Treatment Business (2021–2026)

11.3.5 Novartis Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Nail Psoriasis Treatment Introduction

11.4.4 Pfizer Revenue in Nail Psoriasis Treatment Business (2021–2026)

11.4.5 Pfizer Recent Development

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Nail Psoriasis Treatment Introduction

11.5.4 Eli Lilly Revenue in Nail Psoriasis Treatment Business (2021–2026)

11.5.5 Eli Lilly Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

 Table 1. Global Nail Psoriasis Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

 Table 2. Key Players of Topical Corticosteroids

 Table 3. Key Players of Vitamin D Analogues

 Table 4. Key Players of Systemic Biologics

 Table 5. Key Players of Small-molecule Inhibitors

 Table 6. Global Nail Psoriasis Treatment Market Size Growth Rate by Sales Channel (US$ Million): 2021 vs 2025 vs 2032

 Table 7. Key Players of Retail Pharmacies

 Table 8. Key Players of Hospital Pharmacies

 Table 9. Key Players of Online Pharmacies

 Table 10. Global Nail Psoriasis Treatment Market Size Growth Rate by Route of Administration (US$ Million): 2021 vs 2025 vs 2032

 Table 11. Key Players of Topical

 Table 12. Key Players of Oral

 Table 13. Global Nail Psoriasis Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

 Table 14. Global Nail Psoriasis Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 15. Global Nail Psoriasis Treatment Market Size by Region (US$ Million), 2021–2026

 Table 16. Global Nail Psoriasis Treatment Market Share by Region (2021–2026)

 Table 17. Global Nail Psoriasis Treatment Forecasted Market Size by Region (US$ Million), 2027–2032

 Table 18. Global Nail Psoriasis Treatment Market Share by Region (2027–2032)

 Table 19. Nail Psoriasis Treatment Market Trends

 Table 20. Nail Psoriasis Treatment Market Drivers

 Table 21. Nail Psoriasis Treatment Market Challenges

 Table 22. Nail Psoriasis Treatment Market Restraints

 Table 23. Global Nail Psoriasis Treatment Revenue by Players (US$ Million), 2021–2026

 Table 24. Global Nail Psoriasis Treatment Market Share by Players (2021–2026)

 Table 25. Global Top Nail Psoriasis Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Nail Psoriasis Treatment Revenue, 2025

 Table 26. Ranking of Global Top Nail Psoriasis Treatment Companies by Revenue (US$ Million) in 2025

 Table 27. Global 5 Largest Players Market Share by Nail Psoriasis Treatment Revenue (CR5 and HHI), 2021–2026

 Table 28. Global Key Players of Nail Psoriasis Treatment, Headquarters and Area Served

 Table 29. Global Key Players of Nail Psoriasis Treatment, Products and Applications

 Table 30. Global Key Players of Nail Psoriasis Treatment, Date of General Availability (GA)

 Table 31. Mergers and Acquisitions, Expansion Plans

 Table 32. Global Nail Psoriasis Treatment Market Size by Type (US$ Million), 2021–2026

 Table 33. Global Nail Psoriasis Treatment Revenue Market Share by Type (2021–2026)

 Table 34. Global Nail Psoriasis Treatment Forecasted Market Size by Type (US$ Million), 2027–2032

 Table 35. Global Nail Psoriasis Treatment Revenue Market Share by Type (2027–2032)

 Table 36. Global Nail Psoriasis Treatment Market Size by Application (US$ Million), 2021–2026

 Table 37. Global Nail Psoriasis Treatment Revenue Market Share by Application (2021–2026)

 Table 38. Global Nail Psoriasis Treatment Forecasted Market Size by Application (US$ Million), 2027–2032

 Table 39. Global Nail Psoriasis Treatment Revenue Market Share by Application (2027–2032)

 Table 40. North America Nail Psoriasis Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 41. North America Nail Psoriasis Treatment Market Size by Country (US$ Million), 2021–2026

 Table 42. North America Nail Psoriasis Treatment Market Size by Country (US$ Million), 2027–2032

 Table 43. Europe Nail Psoriasis Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 44. Europe Nail Psoriasis Treatment Market Size by Country (US$ Million), 2021–2026

 Table 45. Europe Nail Psoriasis Treatment Market Size by Country (US$ Million), 2027–2032

 Table 46. Asia-Pacific Nail Psoriasis Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 47. Asia-Pacific Nail Psoriasis Treatment Market Size by Region (US$ Million), 2021–2026

 Table 48. Asia-Pacific Nail Psoriasis Treatment Market Size by Region (US$ Million), 2027–2032

 Table 49. Latin America Nail Psoriasis Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 50. Latin America Nail Psoriasis Treatment Market Size by Country (US$ Million), 2021–2026

 Table 51. Latin America Nail Psoriasis Treatment Market Size by Country (US$ Million), 2027–2032

 Table 52. Middle East & Africa Nail Psoriasis Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 53. Middle East & Africa Nail Psoriasis Treatment Market Size by Country (US$ Million), 2021–2026

 Table 54. Middle East & Africa Nail Psoriasis Treatment Market Size by Country (US$ Million), 2027–2032

 Table 55. AbbVie Company Details

 Table 56. AbbVie Business Overview

 Table 57. AbbVie Nail Psoriasis Treatment Product

 Table 58. AbbVie Revenue in Nail Psoriasis Treatment Business (US$ Million), 2021–2026

 Table 59. AbbVie Recent Development

 Table 60. Johnson & Johnson Company Details

 Table 61. Johnson & Johnson Business Overview

 Table 62. Johnson & Johnson Nail Psoriasis Treatment Product

 Table 63. Johnson & Johnson Revenue in Nail Psoriasis Treatment Business (US$ Million), 2021–2026

 Table 64. Johnson & Johnson Recent Development

 Table 65. Novartis Company Details

 Table 66. Novartis Business Overview

 Table 67. Novartis Nail Psoriasis Treatment Product

 Table 68. Novartis Revenue in Nail Psoriasis Treatment Business (US$ Million), 2021–2026

 Table 69. Novartis Recent Development

 Table 70. Pfizer Company Details

 Table 71. Pfizer Business Overview

 Table 72. Pfizer Nail Psoriasis Treatment Product

 Table 73. Pfizer Revenue in Nail Psoriasis Treatment Business (US$ Million), 2021–2026

 Table 74. Pfizer Recent Development

 Table 75. Eli Lilly Company Details

 Table 76. Eli Lilly Business Overview

 Table 77. Eli Lilly Nail Psoriasis Treatment Product

 Table 78. Eli Lilly Revenue in Nail Psoriasis Treatment Business (US$ Million), 2021–2026

 Table 79. Eli Lilly Recent Development

 Table 80. Research Programs/Design for This Report

 Table 81. Key Data Information from Secondary Sources

 Table 82. Key Data Information from Primary Sources

 Table 83. Authors List of This Report

List of Figures

 Figure 1. Nail Psoriasis Treatment Picture

 Figure 2. Global Nail Psoriasis Treatment Market Size Comparison by Type (US$ Million), 2021–2032

 Figure 3. Global Nail Psoriasis Treatment Market Share by Type: 2025 vs 2032

 Figure 4. Topical Corticosteroids Features

 Figure 5. Vitamin D Analogues Features

 Figure 6. Systemic Biologics Features

 Figure 7. Small-molecule Inhibitors Features

 Figure 8. Global Nail Psoriasis Treatment Market Size Comparison by Sales Channel (US$ Million), 2021–2032

 Figure 9. Retail Pharmacies Features

 Figure 10. Hospital Pharmacies Features

 Figure 11. Online Pharmacies Features

 Figure 12. Global Nail Psoriasis Treatment Market Size Comparison by Route of Administration (US$ Million), 2021–2032

 Figure 13. Topical Features

 Figure 14. Oral Features

 Figure 15. Global Nail Psoriasis Treatment Market Size by Application (US$ Million), 2021–2032

 Figure 16. Global Nail Psoriasis Treatment Market Share by Application: 2025 vs 2032

 Figure 17. Dermatology Clinics Case Studies

 Figure 18. Hospital Case Studies

 Figure 19. Other Case Studies

 Figure 20. Nail Psoriasis Treatment Report Years Considered

 Figure 21. Global Nail Psoriasis Treatment Market Size (US$ Million), Year-over-Year: 2021–2032

 Figure 22. Global Nail Psoriasis Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032

 Figure 23. Global Nail Psoriasis Treatment Market Share by Region: 2025 vs 2032

 Figure 24. Global Nail Psoriasis Treatment Market Share by Players in 2025

 Figure 25. Global Nail Psoriasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

 Figure 26. The Top 10 and 5 Players Market Share by Nail Psoriasis Treatment Revenue in 2025

 Figure 27. North America Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 28. North America Nail Psoriasis Treatment Market Share by Country (2021–2032)

 Figure 29. United States Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 30. Canada Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 31. Europe Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 32. Europe Nail Psoriasis Treatment Market Share by Country (2021–2032)

 Figure 33. Germany Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 34. France Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 35. U.K. Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 36. Italy Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 37. Russia Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 38. Ireland Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 39. Asia-Pacific Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 40. Asia-Pacific Nail Psoriasis Treatment Market Share by Region (2021–2032)

 Figure 41. China Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 42. Japan Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 43. South Korea Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 44. Southeast Asia Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 45. India Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 46. Australia & New Zealand Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 47. Latin America Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 48. Latin America Nail Psoriasis Treatment Market Share by Country (2021–2032)

 Figure 49. Mexico Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 50. Brazil Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 51. Middle East & Africa Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 52. Middle East & Africa Nail Psoriasis Treatment Market Share by Country (2021–2032)

 Figure 53. Israel Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 54. Saudi Arabia Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 55. UAE Nail Psoriasis Treatment Market Size YoY Growth (US$ Million), 2021–2032

 Figure 56. AbbVie Revenue Growth Rate in Nail Psoriasis Treatment Business (2021–2026)

 Figure 57. Johnson & Johnson Revenue Growth Rate in Nail Psoriasis Treatment Business (2021–2026)

 Figure 58. Novartis Revenue Growth Rate in Nail Psoriasis Treatment Business (2021–2026)

 Figure 59. Pfizer Revenue Growth Rate in Nail Psoriasis Treatment Business (2021–2026)

 Figure 60. Eli Lilly Revenue Growth Rate in Nail Psoriasis Treatment Business (2021–2026)

 Figure 61. Bottom-up and Top-down Approaches for This Report

 Figure 62. Data Triangulation

 Figure 63. Key Executives Interviewed